NetworkNewsBreaks Archive - Page 368 of 2094

TuesdayApr 02, 2024 3:45 pm

NetworkNewsBreaks – Bravo Multinational Inc. (BRVO) Solidifies Entry into Video Streaming Industry

Bravo (OTC: BRVO), a company actively exploring opportunities in the entertainment, hospitality and technology sectors, is looking at streaming to generate long-term value for its shareholders through high-growth business ventures. “Bravo recently announced entering into a purchase agreement to acquire the assets of Streaming TVEE Inc., solidifying its entry into the video streaming industry. The company’s strategic move establishes the business foundation for the previously announced flagship offering, TVee NOW(TM), which is expected to launch a Beta version during Q1 2024. The streaming service will be available for download in the Roku Channel Store, Apple Store and Google Play Store……

TuesdayApr 02, 2024 3:27 pm

NetworkNewsBreaks – SenesTech Inc. (NASDAQ: SNES) to Present at Emerging Growth Conference

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, today announced that its Chief Executive Officer Joel Fruendt will be participating in the Emerging Growth Conference taking place on April 3-4, 2024. Fruendt’s presentation is scheduled to begin at 3:10 p.m. ET on Wednesday, April 3. Interested parties should visit https://ibn.fm/5l1xW or the investor relations page of the company's website to access the webcast. During the event, Fruendt will update participants on commercial progress SenesTech has made since his last presentation. The announcement provides details regarding requesting one-on-one investor meetings with SenesTech management during the event…

TuesdayApr 02, 2024 3:22 pm

NetworkNewsBreaks – AppTech Payments Corp. (NASDAQ: APCX) Closes on $2M Common Stock Public Offering

AppTech Payments (NASDAQ: APCX), a pioneering fintech company powering frictionless commerce, has closed on a previously announced underwritten public offering. The offering was comprised of 2,000,000 shares of common stock at $1 per share. The offering is valued at an estimated $2 million in gross proceeds, before deducting underwriting discounts and other offering expenses. The announcement noted that APCX also granted the underwriters a 45-day option to purchase up to an additional 300,000 shares of common stock to cover any overallotments. EF Hutton LLC acted as sole bookrunner for the offering. To view the full press release, visit https://nnw.fm/0UC4B About…

TuesdayApr 02, 2024 3:17 pm

NetworkNewsBreaks – Astera Labs Inc. (NASDAQ: ALAB) Announces Pricing of IPO

Astera Labs (NASDAQ: ALAB) has announced the pricing of its initial public offering of 19,800,000 shares of its common stock at a price to the public of $36.00 per share. According to the announcement, the offering consists of 16,788,903 shares of common stock offered by Astera Labs and 3,011,097 shares of common stock to be sold by certain of Astera Labs’ existing stockholders. In addition, the underwriters will have a 30-day option to purchase up to an additional 2,970,000 shares of common stock from Astera Labs at the initial public offering price, less underwriting discounts and commissions. The gross proceeds…

TuesdayApr 02, 2024 3:13 pm

NetworkNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Enters Acquisition Agreement to Acquire Biodefense Vaccine Developer

Aditxt (NASDAQ: ADTX), a company dedicated to discovering, developing and deploying promising health innovations, has signed a definitive arrangement agreement to acquire Appili Therapeutics Inc. (TSX: APLI) (OTCQX: APLIF). Appili is a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures. According to the agreement, Adivir Inc., a wholly owned subsidiary of Aditxt, will acquire all issued and outstanding Class A common shares of Appili. Assets acquired by Aditxt will include FDA-approved LIKMEZ(TM), which is the ATI-1701 tularemia vaccine defense program, and the ATI-1801 topical formulation. “The acquisition of Appili would represent another step in Aditxt’s journey towards…

TuesdayApr 02, 2024 3:11 pm

NetworkNewsBreaks – Astrotech Corp. (NASDAQ: ASTC), Subsidiary Set to Spotlight Tracer 1000 Trace Detector at Leading Security Trade Event

Astrotech (NASDAQ: ASTC), an innovative science and technology company, and its wholly owned subsidiary, 1st Detect Corporation, will be showcasing the TRACER 1000 Narcotics Trace Detector (“NTD”) and Explosives Trace Detector (“ETD”) at the International Security Conference and Exposition. Known as ISC West, the conference and expo is slated to run April 9–12, 2024, in Las Vegas; the event is the one of the leading comprehensive security trade events in the nation and will be attended by key security and public-safety professionals. A high-performance laboratory instrument powered by Astrotech Mass Spectrometer Technology(TM), the TRACER 1000 can detect trace levels of narcotics…

TuesdayApr 02, 2024 3:01 pm

NetworkNewsBreaks – Danimer Scientific Inc. (NYSE: DNMR) Secures ~$15M in Registered Direct

Danimer Scientific (NYSE: DNMR) is a leading next- generation bioplastics company focused on the development and production of biodegradable materials. The company recently announced the closing of its registered direct offering for the purchase and sale of 15,000,000 shares of common stock (or common stock equivalent in lieu thereof) at a purchase price of $1.00 per share (or per common stock equivalent in lieu thereof) and accompanying warrants to purchase up to an aggregate of 15,000,000 shares of common stock. Danimer secured approximately $15 million in gross proceeds, of which it intends to use the net for working capital and…

TuesdayApr 02, 2024 2:50 pm

NetworkNewsBreaks – HealthLynked Corp. (HLYK) Releases Q4, FY 2023 Financial Report Reflect Focus on Core Healthcare Network

HealthLynked (OTCQB: HLYK), a leader in healthcare networking and technological innovation, is reporting financial results for Q4 and full year ended Dec. 31, 2023. A highlight of the report includes that, based on “strategic advancements and its focus on core healthcare technologies and networking capabilities, HealthLynked achieved a significant 70% reduction in net loss for the fourth quarter, highlighting a period of fiscal management and strategic positioning for future growth.” The report noted that the company’s strategic focus and technological innovations are paving the way for an optimistic outlook with optimization of operational expenses leading to a 52% cut in operational losses. In…

TuesdayApr 02, 2024 2:13 pm

NetworkNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Receives Orders from Established Monitoring Provider for Justice, Behavioral Health Use

SOBRSafe (NASDAQ: SOBR), providers of next-generation, transdermal alcohol-detection solutions, has filled purchase orders from Lake Erie Interlock Inc. for both SOBRcheck and SOBRsure devices. According to the announcement, Lake Erie Interlock has “further diversified and expanded its service offering in Ohio” with SOBR solutions, offering point-of-care screening through SOBRcheck and continuous monitoring through SOBRsure throughout the state. The company will be serving probation officers, treatment centers, sober living centers and more. “Since our founding in 1993, our main focus has been on serving customers dealing with the aftermath of alcohol-related problems,” said Lake Erie Interlock president Richard Friedman in the…

TuesdayApr 02, 2024 1:45 pm

NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Positive Preclinical Data Supporting NPRL2 Gene Therapy

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company today announced that its research collaborators have published positive preclinical data for the NPRL2 tumor suppressor gene, utilizing Genprex’s non-viral Oncoprex(R) Delivery System, in KRAS/STK11 mutant anti-PD1 resistant non-small cell lung cancer (“NSCLC”) in a humanized mouse model. “These positive preclinical data are very encouraging and support NPRL2 gene therapy as a potential treatment for a sub-group of NSCLC in which patients traditionally are resistant to existing therapies,” said Rodney Varner, president, chairman and CEO at Genprex. “We…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks